|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||129.33 - 130.67|
|52-week range||129.33 - 130.67|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||48.81|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH), and Medtronic plc (MDT).
With the S&P 500 index (SNPINDEX: ^GSPC) rallying 20% year to date, Morgan Stanley's chief U.S. equity strategist, Mike Wilson, believes that a correction could be around the corner. Medtronic (NYSE: MDT) is the first stock that dividend investors should consider purchasing to shore up their portfolios. As a medical device maker, Medtronic's revenue is derived from elective procedures that are aimed at treating serious cardiovascular, spinal, and other conditions.
Medtronic's (MDT) pilot program offers an advanced and scalable method to use real-world clinical data which enable quicker and appropriate care for patients at-risk of SCA.